Y-mAbs Therapeutics Inc (YMAB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

750 THIRD AVENUE NEW YORK, NY 10017

Y-mAbs Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel antibody therapeutics and medicines for the treatment of cancer patients of all ages. Y-mAbs Therapeutics serves customers in the United States and Denmark.

Data based on most recent fiscal year report
Market Cap1.308 Billion Shares Outstanding39.73 Million Avg Volume213.402 Thousand
1-Yr BETA vs S&P TR1.107 Current Ratio16.62 Quick Ratio16.62
View SEC Filings from YMAB instead.

View recent insider trading info

Funds Holding YMAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding YMAB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.9 Thousand total shares from 1 transactions

Open Market Sells (S)

16 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOLLER-SAN PEDRO CLAUS JUAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
874,828 2020-03-17 2

GAD THOMAS PRESIDENT AND CHAIRMAN

  • Officer
  • Director
1,866,356 2020-03-16 26

GILL DAVID N

  • Director
0 2020-01-23 1

HEALY JAMES

  • Director
  • 10% Owner
0 2020-01-21 3

KRUSE BO EVP, CFO, SECY & TREAS.

  • Officer
  • Director
0 2020-01-07 1

HERMAN PHILIP KARL SR. VP AND CCO

  • Officer
0 2020-01-01 1

AHMED MAHIUDDIN SR. VP AND CSO

  • Officer
260,000 2020-01-01 1

WG BIOTECH APS

  • 10% Owner
5,508,392 2019-12-30 1

WEDELL-WEDELLSBORG JOHAN

  • Director
5,508,392 2019-12-30 10

BER GERARD

0 2019-12-13 1

WILMS JORIS SR. VP & COO

  • Officer
0 2019-12-10 1

LUND-HANSEN TORBEN SR. VP & CTO

  • Officer
0 2019-12-10 1

LISBY STEEN SR. VP & CMO

  • Officer
0 2019-12-10 1

RASKIN GREGORY S

  • Director
0 2019-08-29 2

TYAGI ASHU

  • Director
0 2019-06-12 1

BUSCHLE MICHAEL

  • Director
0 2018-09-20 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MOLLER-SAN PEDRO CLAUS JUAN - Director - Officer CHIEF EXECUTIVE OFFICER by minor child

2020-03-17 P 1,900 $17.22 a 1,900 874,828.00 indirect

GAD THOMAS - Director - Officer PRESIDENT AND CHAIRMAN by gad enterprises llc

2020-03-16 S 4,000 $18.01 d 836,000 1,866,356.00 indirect

GAD THOMAS - Director - Officer PRESIDENT & CHAIRMAN by gad enterprises llc

2020-03-02 S 4,000 $29.18 d 840,000 1,870,356.00 indirect

GAD THOMAS - Director - Officer PRESIDENT & CHAIRMAN by gad enterprises llc

2020-02-18 S 4,000 $32.78 d 844,000 1,874,356.00 indirect

GAD THOMAS - Director - Officer PRESIDENT & CHAIRMAN by gad enterprises llc

2020-02-10 S 4,000 $33.03 d 848,000 1,878,356.00 indirect

Elevate your investments